Everything below concerns AOD-9604. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-03-20. Numbers and descriptions here follow the published literature rather than marketing material.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Peptide fragment | Corresponds to hGH residues 176-191 |
| Common synonyms | AOD9604, hGH 176-191 | Also written as AOD-9604 |
| Typical form | Lyophilized powder | Often supplied in sealed vials |
| Solubility | Water-soluble | Dissolves in aqueous buffers |
| Regulatory status | Not approved as drug | Banned in sport; varies by country |
The addition of S. boulardii to standard triple therapy for the eradication of Helicobacter pylori infection has been associated with a modest but statistically significant increase in eradication rates in a meta-analysis. The same analysis also reported a significant reduction in common adverse effects of eradication therapy, including diarrhea and nausea.
Basic stocks are usually named for the primary meat type. A distinction is usually made between fond blanc, or white stock, made by using raw bones and mirepoix, and fond brun, or brown stock, which gets its color by roasting the bones and mirepoix before boiling; the bones may also be coated in tomato paste before roasting. Chicken is most commonly used for fond blanc, while beef or veal are most commonly used in fond brun. Other regional varieties include:
MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes) is one of the family of mitochondrial diseases, which also include MIDD (maternally inherited diabetes and deafness), MERRF syndrome, and Leber's hereditary optic neuropathy. It was first characterized under this name in 1984. A feature of these diseases is that they are caused by defects in the mitochondrial genome which is inherited purely from the female parent. The most common MELAS mutation is one in mitochondrial DNA (mtDNA) referred to as m.3243A>G.
In many high and middle income countries lower socioeconomic status is a strong predictor of smoking. Smoking rates in the United States have dropped by more than half from 1965 to 2016, falling from 42% to 15.5% of US adults. Australia is cutting their overall smoking consumption faster than most of the developed world, in part due to the landmark Plain Packaging Act, which standardized the appearance of cigarette packs. Other countries have considered similar measures. In New Zealand, a bill has been presented to Parliament which the government's associate health minister said "takes away the last means of promoting tobacco as a desirable product."
== List of nucleosides and corresponding nucleobases == This list does not include modified nucleobases and the corresponding nucleosides Each chemical has a short symbol, useful when the chemical family is clear from the context, and a longer symbol, if further disambiguation is needed. For example, long nucleobase sequences in genomes are usually described by CATG symbols, not Cyt-Ade-Thy-Gua (see Nucleic acid sequence § Notation).
Sources: en.wikipedia.org
The radio telescope was built in 1966 under the supervision of Gindilis to listen at centimeter wavelengths. In 1987, Tarter, Kardashev, and Slysh used the VLA to detect possible infrared sources near the galactic center from the IRAS telescope catalog. All three were looking for evidence of hypothetical Dyson spheres. The objects turn out to be OH/IR type stars. A small-scale search for possible Type III sources was conducted by James Annis in 1999 and published in the Journal of the British Interplanetary Society under the title "Placing a limit on star-fed Kardashev type III civilizations". An astrophysicist at Fermilab (US), Annis studied a sample of 31 galaxies, both spiral and elliptical, using the Tully-Fisher diagram, in which the absolute magnitude is a function of the galaxies' rotational speed. Annis suggested that 75% of the least luminous objects (i.e., those with a decrease in absolute magnitude of 1.5 compared to the diagram) could be considered as possible candidates. However, no object with this characteristic is observed in his survey. On the other hand, Annis uses the available astronomical data to estimate the probability that a Type III civilization could exist. He shows that the average time that could allow for the emergence of such a civilization is 300 billion years, so none can exist in our present Universe. Per Calissendorff conducted a study on a sample of spiral galaxies from two databases: 4,861 from the Spiral Field I-band (SFI++ catalog compiled by Springob et al. in 2005) and 95 from that of Reyes et al. in 2011.
the theoretical predictions align with experimental results. This relation can thus be used to analyse the environment of the nanoparticle, i.e. the interfacial layer, by measuring the wavelength of the plasmon resonance.
== Environment == Endolithic microorganisms have been reported in many areas around the globe. There are reports in warm hyper-arid and arid deserts such as Mojave and Sonora (USA), Atacama (Chile), Gobi (China, Mongolia), Negev (Israel), Namib (Namibia Angola), Al-Jafr basin (Jordan) and the Depression of Turpan (China), also in cold deserts as Arctic and Antarctic, and deep subsoil and ocean trenches rocks. However, there are reports of endolithic microorganisms in inter-tropical zones, where humidity and solar radiation are significantly different from the above-mentioned biomes. Endoliths have been found in the rock down to a depth of 3 km (1.9 mi), though it is unknown if that is their limit (due to the cost involved in drilling to such depths). The main threat to their survival seems not to result from the pressure at such depth, but from the increased temperature. Judging from hyperthermophile organisms, the temperature limit is at about 120 °C (Strain 121 can reproduce at 121 °C), which limits the possible depth to 4-4.5 km below the continental crust, and 7 or 7.5 km below the ocean floor. Endolithic organisms have also been found in surface rocks in regions of low humidity (hypolith) and low temperature (psychrophile), including the Dry Valleys and permafrost of Antarctica, the Alps, and the Rocky Mountains.
effector Also modifier and modulator. Any small molecule or ligand which by interacting with a particular enzyme changes its catalytic activity but is not itself changed. A positive effector enhances the enzyme's activity while a negative effector reduces it.
Morphine ascorbate and other salts such as the tannate, citrate, and acetate, phosphate, valerate and others may be present in poppy tea depending on the method of preparation. The salts listed by the United States Drug Enforcement Administration for reporting purposes, in addition to a few others, are as follows:
Sources: en.wikipedia.org
AOD-9604 is a synthetic peptide fragment of human growth hormone, corresponding to amino acids 176-191. It is studied for potential effects on fat metabolism, but it is not approved as a drug in most countries. Its exact mechanism remains under investigation.
No, it is a small fragment of the full growth hormone protein. It does not appear to stimulate growth or increase growth hormone levels in the same way. Its actions are thought to be more limited to metabolic pathways.
Regulatory status varies. It is not approved for medical use in the United States or many other countries. It is banned in sport by WADA, and its sale as a supplement or research chemical may be subject to legal restrictions.
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.